Leqembi is a prescription medication used to treat certain types of cancer, specifically metastatic non-small cell lung cancer (NSCLC) with specific genetic mutations. It is a targeted therapy that works by blocking the action of a protein called MET, which is involved in the growth and spread of cancer cells.

As a medical professional, I recommend Leqembi to patients who have been diagnosed with NSCLC and have tested positive for the specific genetic mutations that the drug targets. It is important to discuss with your healthcare provider if Leqembi is the right treatment option for you, as it may not be suitable for everyone.

Like all medications, Leqembi can cause side effects. Common side effects may include fatigue, nausea, diarrhea, and changes in liver function tests. It is important to report any side effects to your healthcare provider so they can be properly managed.

It is also important to follow your healthcare provider’s instructions for taking Leqembi, including the dose and schedule. Do not stop taking the medication without consulting your healthcare provider, as this can affect the effectiveness of the treatment.

In conclusion, Leqembi is a targeted therapy that can be an effective treatment option for patients with metastatic NSCLC and specific genetic mutations. If you have been prescribed Leqembi, it is important to work closely with your healthcare provider to monitor your progress and manage any side effects. By following your treatment plan, you can help improve your chances of a positive outcome.